IP Library Granted Patent US 10,413,516
Granted Patent B2
US 10,413,516 · App. 13/890,875 · Granted Sep 17, 2019

Thin film with high load of active ingredient

Inventors: Eric Allen (Camarillo, CA); Robert Steven Davidson (Woodland Hills, CA); Jose Bernardo (Oxnard, CA)
Assignee: CURE Pharmaceutical Corporation
A61K9/7007A61K9/006A61K31/522
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,413,516
App. No.
13/890,875
Granted
Sep 17, 2019
Kind
B2
Abstract

A method of preparing a thin film, the method comprising: (a) mixing a lipid, emulsifier, and solvent to provide a uniform first mixture; (b) contacting an active ingredient with the uniform first mixture to provide a thickened second mixture; (c) contacting a binder with the thickened second mixture to provide a slurry; and (d) hot extruding, casting, and condensing the slurry to provide the thin film; or cooling, shearing, mixing, casting, and condensing the slurry to provide the thin film.

Claims (45)

1. A method of preparing a thin film, the method comprising:

(a) mixing a lipid, emulsifier, and solvent to provide a uniform first mixture;

(b) contacting an active ingredient with the uniform first mixture to provide a thickened second mixture;

(c) contacting a binder with the thickened second mixture to provide a slurry; and one of (d) and (e):

(d) hot extruding, casting, and condensing the slurry to provide the thin film;

(e) cooling, shearing, mixing, casting, and condensing the slurry to provide the thin film, wherein

the active ingredient is present in 30 wt. % to 65 wt. %;

the thin film having a thickness of about 0.01 mm to about 1 mm;

the thin film having a dissolution of about 30-300 seconds when placed in the mouth;

wherein at least 10 wt. % of the active ingredient is encapsulated by the lipid in the form of liposomes, micelles, or both; and

wherein the lipid is present in 4-22 wt. %, and is selected from at least one of hydroxylated lecithin and deodorized cocoa butter; and

wherein the thin film includes 0-0.1 wt. % preservative selected from at least one of benzoate salt, sorbate salt, and natamycin.

2. The method of claim 1 , wherein the mixing comprises blending, carried out at a temperature of about 130-140° F. (54.4-60° C.).

3. The method of claim 1 , wherein the contacting of the active ingredient with the uniform first mixture comprises initially contacting a non-sticky binder with the uniform first mixture, and subsequently contacting a sticky binder with the uniform first mixture.

4. The method of claim 1 , wherein the contacting of the active ingredient with the uniform first mixture comprises initially contacting microcrystalline cellulose with the uniform first mixture, and subsequently contacting pectin with the uniform first mixture.

5. The method of claim 1 , wherein the condensing comprises heating at a temperature of at least 50° F. (10° C.).

6. The method of claim 1 , further comprising contacting a powder coating with two opposing external sides of the thin film.

7. The method of claim 6 , wherein the powder coating comprises at least one of talc and microcrystalline cellulose.

8. The method of claim 1 , wherein the solvent comprises at least one of water and ethanol.

9. The method of claim 1 , wherein the solvent is present in about 2-24 wt. %.

10. The method of claim 1 , wherein the binder is present in about 4-50 wt. %.

11. The method of claim 1 , wherein the lipid is present in about 4-22 wt. %.

12. The method of claim 1 , wherein the emulsifier is present in about 3-22 wt. %.

13. A method of preparing a thin film, the method comprising:

(a) blending at a temperature of about 130-140° F. a lipid, emulsifier, and solvent to provide a uniform first mixture;

wherein the solvent comprises at least one of water and ethanol;

wherein the lipid is present in 4-22 wt. %, and is selected from at least one of hydroxylated lecithin and deodorized cocoa butter; wherein the emulsifier comprises at least one of glycerin, propylene glycol, and polyethylene glycol;

(b) contacting an active ingredient with the uniform first mixture to provide a thickened second mixture;

wherein the active ingredient is present in 30 wt. % to 65 wt. % and at least 10 wt. % is encapsulated by the lipid in the form of liposomes, micelles, or both;

(c) contacting a binder with the thickened second mixture to provide a slurry;

wherein the binder comprises at least one of pectin, microcrystalline cellulose, xanthan gum, locust bean gum, guar gum, gum arabic, gum tragacanth, gum karaya, beta glucan, glucomannan, tapioca starch, carrageenan, xanthan gum, gellan gum, alginic acid or sodium alginate, konjac gum, tara gum, chitosan, agar, maltodextrin, polyvinyl alcohol, pullulan, polycarbophil, povidone, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxypropyl starch, and sodium carboxymethyl cellulose;

(d) hot extruding, casting, and condensing the slurry to provide the thin film; or cooling, shearing, mixing, casting, and condensing the slurry to provide the thin film; and

(e) contacting a powder coating with two opposing external sides of the thin film;

wherein the powder coating comprises at least one of talc and microcrystalline cellulose;

the thin film having a thickness of about 0.01 mm to about 1 mm; and

the thin film having a dissolution of about 30-300 seconds when placed in the mouth; and

wherein the thin film includes 0-0.1 wt. % preservative selected from at least one of benzoate salt, sorbate salt, and natamycin.

14. The method of claim 1 , wherein the binder comprises at least one of pectin, microcrystalline cellulose, xanthan gum, locust bean gum, guar gum, gum arabic, gum tragacanth, gum karaya, beta glucan, glucomannan, tapioca starch, carrageenan, xanthan gum, gellan gum, alginic acid or sodium alginate, konjac gum, tara gum, chitosan, agar, maltodextrin, polyvinyl alcohol, pullulan, polycarbophil, povidone, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxypropyl starch, and sodium carboxymethyl cellulose.

15. The method of claim 1 , wherein the emulsifier comprises at least one of glycerin, propylene glycol, and polyethylene glycol.

16. The method of claim 1 , wherein the active ingredient is present in about 30-45 wt. % of the thin film.

17. The method of claim 1 , wherein at least 50 wt. % of the active ingredient is encapsulated by the lipid.

18. The method of claim 1 , wherein the lipid encapsulates the active ingredient by the formation of liposomes.

19. The method of claim 1 , wherein the lipid encapsulates the active ingredient by the formation of multilamellar liposomes.

20. The method of claim 1 , wherein the lipid encapsulates the active ingredient by the formation of micelles.

21. The method of claim 1 , further comprising contacting a powder coating with the external sides of the thin film.

Assignments (7)
LIEN Recorded Jan 28, 2025
From: CURE PHARMACEUTICAL, INC.
To: CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V.
Reel/Frame 070027/0201 →
CHANGE OF NAME Recorded Jul 17, 2023
From: TF TECH VENTURES, INC.
To: CURE PHARMACEUTICAL, INC.
Reel/Frame 064286/0450 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME WHICH SHOULD READ TF TECH VENTURES, INC. AND NOT TF TECH VENTURES PREVIOUSLY RECORDED AT REEL: 060598 FRAME: 0016. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 12, 2023
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES, INC.
Reel/Frame 064256/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2022
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES
Reel/Frame 060598/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2022
From: CURE PHARMACEUTICAL HOLDING CORP.
To: CURE PHARMACEUTICAL CORPORATION
Reel/Frame 060516/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2020
From: CURE PHARMACEUTICAL CORPORATION
To: CURE PHARMACEUTICAL HOLDING CORP.
Reel/Frame 054445/0736 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: ALLEN, ERIC; DAVIDSON, ROBERT STEVEN; BERNARDO, JOSE
To: CURE PHARMACEUTICAL CORPORATION
Reel/Frame 033065/0521 →
Continuity (1)
Related Publication 20140333003A1 · Nov 13, 2014
Cited By (1)
US 12,544,338